Pfizer Deal Sweetens Onyx Pot - Presented by: The Aol. On Network

Onyx's deal with Pfizer will be a sweetener as bidding for the biotech gets more intense, says Adam Feuerstein, senior columnist at TheStreet.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
CBS $ 63.93 0.54 ▲ 0.85%
SIRI $ 3.35 0.02 ▼ 0.45%
AA $ 15.69 0.84 ▲ 5.66%
FB $ 64.97 2.21 ▲ 3.52%
BAC $ 15.60 0.02 ▲ 0.13%
MU $ 32.89 0.24 ▼ 0.72%
GE $ 26.32 0.05 ▼ 0.19%
AAPL $ 95.39 0.04 ▲ 0.04%

As of 7/9/2014, 04:08 PM
More Most Active